Shinpoong to launch new malaria drug

Published: 2011-03-22 06:58:00

Updated: 2011-03-22 06:58:00

Shinpoong Pharmaceutical says it will release a new malaria drug Pyramax in the world pharmaceutical market as the company completed the Phase III trial.

So far, Shinpong and Medicines for Malaria Venture (MMW) have worked together to develop a new Artemisinin-based Combination Therapy (ACT) t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK